Regulatory T cells attenuate Th17 cell-mediated nigrostriatal dopaminergic neurodegeneration in a model of Parkinson’s disease AD Reynolds, DK Stone, JAL Hutter, EJ Benner, RL Mosley, ... The Journal of Immunology 184 (5), 2261-2271, 2010 | 404 | 2010 |
CD4+ regulatory and effector/memory T cell subsets profile motor dysfunction in Parkinson’s disease JAH Saunders, KA Estes, LM Kosloski, HE Allen, KM Dempsey, ... Journal of Neuroimmune Pharmacology 7, 927-938, 2012 | 311 | 2012 |
Inflammation and adaptive immunity in Parkinson’s disease RL Mosley, JA Hutter-Saunders, DK Stone, HE Gendelman Cold Spring Harbor perspectives in medicine 2 (1), a009381, 2012 | 287 | 2012 |
Neuromagnetic evidence of abnormal movement-related beta desynchronization in Parkinson's disease E Heinrichs-Graham, TW Wilson, PM Santamaria, SK Heithoff, ... Cerebral cortex 24 (10), 2669-2678, 2014 | 168 | 2014 |
Expression of CD39 on activated T cells impairs their survival in older individuals F Fang, M Yu, MM Cavanagh, JH Saunders, Q Qi, Z Ye, S Le Saux, ... Cell reports 14 (5), 1218-1231, 2016 | 126 | 2016 |
The neurology of AIDS HE Gendelman Oxford University Press, USA, 2005 | 77 | 2005 |
Prion Interference Is Due to a Reduction in Strain-Specific PrPSc Levels JC Bartz, ML Kramer, MH Sheehan, JAL Hutter, JI Ayers, RA Bessen, ... Journal of virology 81 (2), 689-697, 2007 | 73 | 2007 |
Murine motor and behavior functional evaluations for acute 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP) intoxication JAL Hutter-Saunders, HE Gendelman, RL Mosley Journal of Neuroimmune Pharmacology 7, 279-288, 2012 | 55 | 2012 |
Adaptive immune regulation of glial homeostasis as an immunization strategy for neurodegenerative diseases LM Kosloski, DM Ha, JAL Hutter, DK Stone, MR Pichler, AD Reynolds, ... Journal of neurochemistry 114 (5), 1261-1276, 2010 | 51 | 2010 |
Pathways towards an effective immunotherapy for Parkinson’s disease JAL Hutter-Saunders, RL Mosley, HE Gendelman Expert review of neurotherapeutics 11 (12), 1703-1715, 2011 | 47 | 2011 |
Immune checkpoint function of CD85j in CD8 T cell differentiation and aging CE Gustafson, Q Qi, J Hutter-Saunders, S Gupta, R Jadhav, E Newell, ... Frontiers in immunology 8, 269636, 2017 | 35 | 2017 |
BL-1023 improves behavior and neuronal survival in 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-intoxicated mice JAL Hutter-Saunders, LM Kosloski, JM McMillan, N Yotam, T Rinat, ... Neuroscience 180, 293-304, 2011 | 13 | 2011 |
Inflammation and adaptive immunity in Parkinson’s disease. Cold Spring Harb Perspect Med 2: a009381 RL Mosley, JA Hutter-Saunders, DK Stone, HE Gendelman Disclosure statement: Sponsored: CAPES, CNPq, Fundaçao Araucária, 2012 | 8 | 2012 |
Method for diagnosing and treating Parkinson's disease via measurment of effector memory t-cells HE Gendelman, RL Mosley, JA Saunders US Patent 11,209,426, 2021 | 1 | 2021 |
Motor Function in Rodent Models of Neurodegenerative Disorders JAH Saunders, MV Kuenstling, RA Weir, RL Mosley, HE Gendelman Current Laboratory Methods in Neuroscience Research, 467-482, 2014 | 1 | 2014 |
Methods and compositions for diagnosing neurodegenerative disease HE Gendelman, RL Mosley, JA Saunders US Patent App. 17/544,007, 2022 | | 2022 |
ADAPTIVE IMMUNITY JAL Hutter-Saunders, LY Poluektova, S Dhawan, HE Gendelman The Neurology of AIDS, 131, 2011 | | 2011 |
The Journey from Mice to Men: the Role of T Cells in the Immunobiology of Parkinson's Disease J Saunders, DK Stone, AD Reynolds, LM Kosloski, DG Standaert, ... MOVEMENT DISORDERS 25, S617-S617, 2010 | | 2010 |
Vaccine Strategy for Parkinson's Disease Protects Against TH17 Cell-Mediated Nigrostriatal Neurodegeneration in MPTP Mouse Model. DK Stone, AR Reynolds, JA Hutter, RL Mosley, HE Gendelman JOURNAL OF NEUROIMMUNE PHARMACOLOGY 5, S34-S35, 2010 | | 2010 |